Observational, Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus.

Trial Profile

Observational, Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2016

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms PREDICTIVE
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 11 Sep 2009 Actual patient number (2098) added as reported by ClinicalTrials.gov.
    • 01 Dec 2008 Status changed from active, no longer recruiting to completed, according to clinicaltrials.gov.
    • 01 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top